The Bundaberg Tragedy: Contaminated Vaccine Kills 12 Children (1928)
On 27 January 1928, a routine diphtheria immunisation program in the Queensland town of Bundaberg turned catastrophic when a contaminated vaccine killed 12 children within hours. The disaster, later known as the Bundaberg tragedy, exposed dangerous gaps in vaccine manufacturing and handling, and its aftermath reshaped how vaccines were produced, stored, and regulated around the world.
A Routine Vaccination Turns Deadly
In the summer of 1928, local health authorities in Bundaberg, a sugar-growing town in Queensland, Australia, organised a diphtheria immunisation clinic for local children, a standard public health measure of the era. On the morning of 27 January, 21 children lined up to receive injections from a single multi-dose vial of toxin-antitoxin vaccine, produced by the Commonwealth Serum Laboratories (CSL) in Melbourne. Within hours of receiving their shots, many of the children fell gravely ill, developing high fevers, vomiting, and severe shock. Twelve of them died, most within 24 hours of vaccination, while several others survived only after intensive medical intervention. The speed and severity of the reactions stunned the small community and horrified the nation, as parents who had brought their children in for routine protection instead watched them succumb to a sudden and mysterious illness. The scale of the tragedy, concentrated in a single morning and a single town, made it one of the worst medical disasters in Australian history and immediately drew national and international attention to the safety of vaccine production and administration.
Did You Know?
The children who died had all received doses drawn from the same vaccine vial later in its use, meaning the order in which a child was vaccinated that morning directly affected their risk—those inoculated earlier from the freshly opened vial largely survived, while those vaccinated later succumbed to the toxin that had multiplied inside it.
Uncovering the Cause
Investigators quickly focused on the vaccine vial itself, which had been opened and used across multiple sessions rather than being discarded after a single use. Laboratory analysis revealed that the vaccine had become contaminated with Staphylococcus aureus, a common bacterium that, under the right conditions, produces potent toxins capable of triggering toxic shock in the human body. Queensland's tropical heat likely accelerated bacterial growth once the vial's rubber seal was repeatedly punctured by needles, allowing contaminants to enter and multiply in the multi-dose container over the days it remained in use. Crucially, the vaccine contained no antimicrobial preservative to inhibit such bacterial growth, a common practice omission at the time. This meant that later doses drawn from the same vial carried a far higher bacterial and toxin load than the first, explaining why the children vaccinated later in the sequence suffered the most severe reactions. The findings pointed not to a single act of negligence but to a systemic vulnerability in how multi-dose biological products were manufactured, stored, and handled in clinical settings across Australia and much of the world.
The Royal Commission and Lasting Reforms
The Australian government swiftly convened a royal commission to investigate the deaths, examining every stage of the vaccine's production, transport, and administration. The commission's findings confirmed that Staphylococcus aureus contamination of the unpreserved multi-dose vial was responsible for the fatal toxic reactions, and it delivered pointed recommendations for reform. These included mandating the addition of antimicrobial preservatives to vaccine formulations, promoting the use of single-dose ampoules to eliminate the risks of repeated puncturing, and tightening sterile handling protocols in clinical settings. The tragedy became a pivotal case study in the emerging science of vaccine safety and directly influenced the strengthening of biological product regulation in Australia, contributing to the eventual establishment of more rigorous national oversight of vaccines and serums. Internationally, the Bundaberg tragedy was cited for decades afterward as a cautionary example in pharmacology and public health literature, reinforcing global adoption of preservatives in multi-dose vials and stricter manufacturing standards. Though it caused immense grief for the Bundaberg community, the disaster ultimately drove reforms that made vaccination programs markedly safer for generations of children worldwide.